alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James A. Wylie, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Diomed Holdings,
Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures as of the end of the period covered by
this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of the internal control over financial reporting, to
the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.





Date:  August 11, 2006                       /s/ JAMES A. WYLIE, JR.
                                             -------------------------------
<PAGE>

                                                              EXHIBIT 10.35
                                                                Page 1


                     MODIFICATION OF LOAN AND SECURITY AGREEMENT




    WHEREAS, this agreement is in reference to a loan which is evidenced by 
an instrument entitled LOAN AND SECURITY AGREEMENT ("AGREEMENT"), dated May 
21, 1996, executed by and between LEE PHARMACEUTICALS as "BORROWER" and 
PREFERRED BUSINESS CREDIT, INC. ("PBC"), as "LENDER."
    
    NOW THEREFORE, it is agreed by the undersigned parties that the AGREEMENT 
shall be amended in the following respect:
    
    In Section 2.1(a) of the AGREEMENT, PBC agrees to make revolving advances 
to Borrower in an amount equal to the lesser of (I) Seventy percent (70%) of 
the amount of Eligible Accounts; and (II) an amount equal to Borrower's cash 
collections for the immediately preceding forty-five (45) day period.
    
    Except as noted above, all the terms, conditions and provisions of said 
AGREEMENT shall remain unchanged and in full force and effect.
    
    
    
DATE:    September 10, 1997

PREFERRED BUSINESS CREDIT, INC.   AGREED AND ACCEPTED:
                                  LEE PHARMACEUTICALS
BY:
         Farhad Motia
-------------------------------
    Farhad Motia, President
                                  BY:  Ronald G. Lee       
                                     -------------------------
                                  Ronald G. Lee, President
Exhibit 10.1



 Exhibit 10.1 

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY 

Our non-employee directors receive an annual retainer of $35,000. In addition, all non-employee directors who serve on one or more committees
are eligible to receive the following committee fees: 
  

									
	 Committee
	  	Chair	 	  	Member	 
	 Audit
	  	$	20,000	  	  	$	10,000	  
	 Compensation
	  	 	15,000	  	  	 	7,500	  
	 Nominating and Corporate Governance
	  	 	10,000	  	  	 	5,000	  

 Other than the annual retainers and committee fees described above, non-employee directors are not entitled to
receive any cash fees in connection with their service on our Board. Beginning in 2015, each non-employee director will be granted an annual stock option for 12,500 shares at each annual stockholders’ meeting provided the non-employee director
has served since March 1st of the year the annual meeting is held and continues to serve. The annual stock options will vest monthly over one year from the date of grant. New non-employee
directors will receive an initial stock option grant for 25,000 shares of common stock. The initial grant will vest 25% in one year and monthly thereafter over the next three years provided the non-employee director continues to serve. Prior to the
beginning of each year, each non-employee director may elect to receive their annual retainer for the following year in the form of a stock option that will vest quarterly over one year from the date of grant. 

We have a policy of reimbursing our directors for their reasonable out-of-pocket expenses in connection with attending Board of Directors and
committee meetings.
#### James B. Corbett, Resp’t, *v.*The Twenty-Third Street-Railway Company, App’lt.1

*(Court of Appeals, Second Division,*

*Filed June*25, *1889.)*

1. Abatement and revival — Action for personal injuries — When-abated—Code Civil Pro., § 764.

The rule of the common law, that an action for the recovery of damages for a personal injury, abates on the death of the plaintiff, is not changed by Code Civil Procedure, § 764, unless a verdict, report or decision has been rendered upon the issues.

2. Same—Code Civil Pro., § 764.

The word “ decision,” as used in section 764, refers to a decision made by a court upon a trial of issues without a jury.

8. Same—Appeal—Code Civil Pro., § 191, subd. 1.

It was not intended by the legislature that the stipulation provided for in the Code Civil Procedure, § 191, subd. 1, should relate to, or affect the survivability of causes of action, or abatement of actions.

Appeal from an order of the supreme court, general term, first department, reversing a judgment entered on a non-suit at trial term.

*Sermon S.*Shook, for motion; *Leslie W.*Russell, opposed.

1

 See 4 N Y. State Rep., 535.

Rollett, Oh. J.

This action is for a recovery of damages for a personal injury (Code Civ. Pro., § 3343, subd. 9), and the rule of the common law that such an action abates on the death of the plaintiff is not changed by section 764 of the Code of Civil Procedure, unless a verdict, report or decision has been rendered upon the issues. ■ Neither a verdict nor a report has been rendered in this action. The word “ decision,” as used in this section, refers to a decision made by a court upon a trial of issues without a jury. Code Civil Pro., § 3343, subd. 5. This action was not tried by the court without a jury and the non-suit is not a decision, within the meaning of section 764. The order of the general term, reversing the judgment entered on the non-suit, was not made upon the hearing or trial of the issues and is not a decision within the meaning of the section last cited.

The stipulation given by the defendant upon appealing to this court does not prevent the abatement of the action. The lawmaking power did not intend that the stipulation provided for in subdivision 1 of section 191 should relate to, or affect the survivability of causes of action, or the abatement of actions, nor did either of the parties to this action intend that the stipulation should affect, or have any relation to the abatement of the action, or to the survivability of the cause of action. The action has. abated and the court is without power to revive it.

The motion to revive should be denied, with costs.

All concur.
# Fourth Court of Appeals **San Antonio, Texas**

JUDGMENT

No. 04

- 18

- 00609

- CV Allison Tracy WHITE , Appellant

v.
Jason WALSH , Appellee From the 285th Judicial District Court, Bexar County, Texas Trial Court No. 2014

- CI

- 02528 Honorable Stephani A. Walsh, Judge Presiding

BEFORE JUSTICE MARTINEZ , JUSTICE WATKINS , AND JUSTICE RODRIGUEZ In accordance with this court’s opinion of this date, the trial court’s order in Cause No. 2014

- CI

- 02528 dismissing the suit for want of prosecution is REVERSED and t his matter is REMAN D ED to the trial court with instructions for the trial court to reinstate Cause No. 2014

- CI

02528 on the court’s active docket. It is ORDERED that appellant Allison Tracy White recover her costs of this appeal from appellee Jason Walsh.

SIGNED July 31, 2019.

_____________________________ Rebeca C. Martinez, Justice
Electronically Filed

Intermediate Court of Appeals

CAAP-17-0000525

06-DEC-2018

10:20 AM
<PAGE>

                                                              EXHIBIT 10.18
                                                              Note 1

                                  STRAIGHT NOTE


$250,000       South El Monte, California    December 23, 1994
--------

     For value received, Lee Pharmaceuticals promises to pay Henry L. Lee, Jr.
or order, at South El Monte, California the sum of TWO HUNDRED AND FIFTY
THOUSAND DOLLARS, with interest from December 23, 1994, on unpaid principal at
the rate of Imperial Bank Prime Rate per cent per annum; principal payable on
June 30, 1998.  Interest shall be calculated on the basis of the unpaid
principal balance daily, based on a 365 day year, actual day month, payable
monthly. Principal and interest shall be payable in lawful money of the United
States.  If action be instituted on this note, I promise to pay such sum as the
Court may fix as attorney's fees.  This note is unsecured.



December 27, 1994                  RONALD G. LEE
-------------------                -------------------------------
Date                               Lee Pharmaceuticals - Ronald G. Lee


December 27, 1994                  MICHAEL L. AGRESTI
---------------------              ---------------------------------
Date                               Lee Pharmaceuticals - Michael L. Agresti


<PAGE>

                                                                 EXHIBIT 10.18
                                                                 Note 2


                                  STRAIGHT NOTE


   $38,000         South El Monte, California       April 12, 1995
-------------

For value received, Lee Pharmaceuticals promises to pay Ronald G. Lee or order,
at South El Monte, California the sum of THIRTY-EIGHT THOUSAND DOLLARS, with
interest from February 17, 1995 on unpaid principal at the rate of Imperial Bank
Prime Rate per cent per annum; principal payable on March 21, 1997.  Interest
shall be calculated on the basis of the unpaid principal balance daily, based on
a 365 day year, actual day month, payable semi-annually (August 17 and February
17). Principal and interest shall be payable in lawful money of the United
States.  If action be instituted on this note, I promise to pay such sum as the
Court may fix as attorney's fees.  This note is secured by the product brand
Aloe E and Aloe 99.




February 17, 1995                       RONALD G. LEE
-------------------------------         ----------------------------------------
Date                                    Lee Pharmaceuticals - Ronald G. Lee


February 17, 1995                       MICHAEL L. AGRESTI
------------------------------          ----------------------------------------
Date                                    Lee Pharmaceuticals - Michael L. Agresti
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

                    The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841*et seq.*) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.                

The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States.

Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 8, 2011.

A. Federal Reserve Bank of Cleveland (Nadine Wallman, Vice President) 1455 East Sixth Street, Cleveland, Ohio 44101-2566:

                    1.                     *The PNC Financial Services Group, Inc.,*                     Pittsburgh, Pennsylvania, and PNC Bancorp, Inc., Wilmington, Delaware; to acquire voting shares of RBC Bank (USA), Raleigh, North Carolina.                

Board of Governors of the Federal Reserve System, August 9, 2011.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 2011-20592 Filed 8-12-11; 8:45 am]

BILLING CODE 6210-01-P
§ 1918.25 Bridge plates and ramps (See also § 1918.86). ( a ) *Bridge and car plates (dockboards).* Bridge and car plates used afloat shall be well maintained and shall: ( 1 ) Be strong enough to support the loads imposed on them;
( 2 ) Be secured or equipped with devices to prevent their dislodgement;
( 3 ) Be equipped with hand holds or other effective means to permit safe handling; and
( 4 ) Be designed, constructed, and maintained to prevent vehicles from running off the edge.[3]
( b ) *Portable ramps.* Portable ramps used afloat shall be well maintained and shall: ( 1 ) Be strong enough to support the loads imposed on them;
( 2 ) Be equipped with a railing meeting the requirements of § 1918.21(b), if the slope is more than 20 degrees to the horizontal or if employees could fall more than four feet (1.22 m);
( 3 ) Be equipped with a slip resistant surface;
( 4 ) Be properly secured; and
( 5 ) Be designed, constructed, and maintained to prevent vehicles from running off the edge.[4]
[62 FR 40202, July 25, 1997, as amended at 65 FR 40944, June 30, 2000] Footnotes -
1918.25
[3] When the gap to be bridged is greater than 36 inches (.91m), an acceptalbe means of preventing vehicles from running off the edge is a minimum side board height of two and three-quarter inches.
[4] When the gap to be bridged is greater than 36 inches (.91m), an acceptable means of preventing vehicles from running off the edge is a minimum side board height of two and three-quarter inches.
[Federal Register Volume 76, Number 155 (Thursday, August 11, 2011)]
[Notices]
[Page 49802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-20612]


=======================================================================
-----------------------------------------------------------------------

POSTAL SERVICE


Board of Governors; Sunshine Act Meeting

    Board Votes To Close July 25, 2011, Meeting.
    By telephone vote on July 25, 2011, a majority of the members of 
the Board of Governors of the United States Postal Service met and 
voted unanimously to close to public observation its meeting held in 
Washington, DC, via teleconference. The Board determined that no 
earlier public notice was possible.

ITEMS CONSIDERED: 
    1. Strategic Issues.
    2. Financial Matters.
    3. Pricing.
    4. Personnel Matters and Compensation Issues.

GENERAL COUNSEL CERTIFICATION: The General Counsel of the United States 
Postal Service has certified that the meeting was properly closed under 
the Government in the Sunshine Act.

CONTACT PERSON FOR MORE INFORMATION: Requests for information about the 
meeting should be addressed to the Secretary of the Board, Julie S. 
Moore, at (202) 268-4800.

Julie S. Moore,
Secretary.
[FR Doc. 2011-20612 Filed 8-9-11; 4:15 pm]
BILLING CODE 7710-12-P
Exhibit 32.1

LOUISIANA-PACIFIC CORPORATION

411 Union Street,
Suite 2000

Nashville, TN 37219-1700

(615)986-5600

March 1, 2010

Securities and Exchange Commission

Judiciary
Plaza

450 Fifth Street, N.W.

Washington, D.C. 20549



| | Re: | Certification Pursuant to § 906 of the Sarbanes-Oxley Act of 2002
| | --- | -----------------------------------------------------------------

Ladies and Gentlemen:

Pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Form 10-K of Louisiana-Pacific Corporation (the Company) for the fiscal year ended December 31, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the Report), each of the undersigned officers of the Company certifies, that, to such officers knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and
for the periods expressed in the Report.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



/S/ RICHARD W. FROSTName: Richard W. Frost Title: Chief Executive Officer




/S/ CURTIS M. STEVENSName: Curtis M. Stevens Title: Chief Financial Officer


A signed original of this written statement required by Section 906 has
been provided to Louisiana-Pacific Corporation and will be retained by Louisiana-Pacific Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Federal Register Volume 65, Number 103 (Friday, May 26, 2000)]
[Notices]
[Page 34156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-13228]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. ER00-2251-001, ER97-705-012, ER98-2491-007 and ER99-2251-
001]

Consolidated Edison Company of New York, Inc., Consolidated 
Edison Solutions, Inc., Consolidated Edison Energy, Inc. and Orange and 
Rockland Utilities, Inc.; Notice of Filing

May 22, 2000.
    Take notice that on May 5, 2000, Consolidated Edison Company of New 
York, Inc. (Con Edison), on behalf of itself and its affiliates 
Consolidated Edison Solutions, Inc., Consolidated Edison Energy, Inc., 
and Orange and Rockland Utilities, Inc. submitted an updated market 
power analysis.
    Con Edison states that a copy of the filing was served on the New 
York Public Service Commission.
    Any person desiring to be heard or to protest such filing should 
file a motion to intervene or protest with the Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in 
accordance with Rules 211 and 214 of the Commission's Rules of Practice 
and Procedure (18 CFR 385.211 and 385.214). All such motions and 
protests should be filed on or before June 1, 2000. Protests will be 
considered by the Commission to determine the appropriate action to be 
taken, but will not serve to make protestants parties to the 
proceedings. Any person wishing to become a party must file a motion to 
intervene. Copies of this filing are on file with the Commission and 
are available for public inspection. This filing may also be viewed on 
the Internet at http://www.ferc.fed.us/online/rims.htm (call 202-208-
2222 for assistance).

Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 00-13228 Filed 5-25-00; 8:45 am]
BILLING CODE 6717-01-M
```
Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Amended Quarterly Report ofMaverick Minerals Corporation (the "Company") on Form 10-QSB/A-1 for the period ended March 31, 2006 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Robert Kinloch, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) 	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) 	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 9th day of June, 2006.



|                                                    | ROBERT KINLOCH
|--------------------------------------------------- | --------------
|Robert Kinloch                                     
|Chief Executive Officer and Chief Financial Officer















---
Argued and submitted March 31,

affirmed May 12, 1993

#### STATE OF OREGON, *Respondent, v.*JEFFREY BRYANT DAVIS, *Appellant.*

(C91-09-34611; CA A74262)

851 P2d 635

Jesse Wm. Barton, Deputy Public Defender, Salem, argued the cause for appellant. With him on the brief was Sally L. Avera, Public Defender, Salem.

Timothy A. Sylwester, Assistant Attorney General, Salem, argued the cause for respondent. With him on the brief were Theodore R. Kulongoski, Attorney General, and Virginia L. Linder, Solicitor General, Salem.

Before Warren, Presiding Judge, and Edmonds and De Muniz, Judges.

PER CURIAM

Affirmed. *State v. Munro,*109 Or App 188, 818 P2d 971 (1991).